Abdul, F.; Ribaux, P.; Caillon, A.; Malézieux-Picard, A.; Prendki, V.; Vernaz, N.; Zhukovsky, N.; Delhaes, F.; Krause, K.-H.; Preynat-Seauve, O.
A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination. Viruses 2022, 14, 2118.
https://doi.org/10.3390/v14102118
AMA Style
Abdul F, Ribaux P, Caillon A, Malézieux-Picard A, Prendki V, Vernaz N, Zhukovsky N, Delhaes F, Krause K-H, Preynat-Seauve O.
A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination. Viruses. 2022; 14(10):2118.
https://doi.org/10.3390/v14102118
Chicago/Turabian Style
Abdul, Fabien, Pascale Ribaux, Aurélie Caillon, Astrid Malézieux-Picard, Virginie Prendki, Nathalie Vernaz, Nikolay Zhukovsky, Flavien Delhaes, Karl-Heinz Krause, and Olivier Preynat-Seauve.
2022. "A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination" Viruses 14, no. 10: 2118.
https://doi.org/10.3390/v14102118
APA Style
Abdul, F., Ribaux, P., Caillon, A., Malézieux-Picard, A., Prendki, V., Vernaz, N., Zhukovsky, N., Delhaes, F., Krause, K.-H., & Preynat-Seauve, O.
(2022). A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination. Viruses, 14(10), 2118.
https://doi.org/10.3390/v14102118